Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 3Osteoporosis 1Infertility, Female 1Infertility 1Coronary Disease 1Cardiovascular Diseases 1Breast Neoplasms 1Abortion, Spontaneous 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Progesterone × Clear all
NCT01698164 2012-10-02

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

Peking Union Medical College Hospital

Phase 4 Unknown
1,200 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Coronary Disease, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡